Cory AH - Search Results

1

Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine.

Cory JG, Cory AH, Long SD, Carter GL, Johnson CE. Cory JG, et al. Among authors: cory ah. Cancer Res. 1992 Apr 1;52(7):2000-3. Cancer Res. 1992. PMID: 1551129

2

In vivo growth of mouse leukemia L1210 cells with metabolic alterations in the subunits of ribonucleotide reductase.

Somerville L, Cory AH, Cory JG. Somerville L, et al. Among authors: cory ah, cory jg. In Vivo. 2002 May-Jun;16(3):175-7. In Vivo. 2002. PMID: 12182112

3

Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.

Cory AH, Cory JG. Cory AH, et al. Among authors: cory jg. Anticancer Res. 2002 Nov-Dec;22(6C):3805-9. Anticancer Res. 2002. PMID: 12552998

4

Gemcitabine-induced apoptosis in a drug-resistant mouse leukemia L1210 cell line that does not express p53.

Cory AH, Cory JG. Cory AH, et al. Adv Enzyme Regul. 2004;44:11-25. doi: 10.1016/j.advenzreg.2003.11.011. Adv Enzyme Regul. 2004. PMID: 15581479 No abstract available.

5

Phenolic compounds, sodium salicylate and related compounds, as inhibitors of tumor cell growth and inducers of apoptosis in mouse leukemia L1210 cells.

Cory AH, Cory JG. Cory AH, et al. In Vivo. 2005 Jan-Feb;19(1):31-5. In Vivo. 2005. PMID: 15796154 Free article.

6

Induction of apoptosis in p53-deficient L1210 cells by an I-kappa-B-alpha-inhibitor (Bay 11-7085) via a NF-kappa-B-independent mechanism.

Cory AH, Cory JG. Cory AH, et al. Adv Enzyme Regul. 2005;45:85-93. doi: 10.1016/j.advenzreg.2005.02.003. Epub 2005 Aug 29. Adv Enzyme Regul. 2005. PMID: 16129475

7

Effects of PRIMA-1 on wild-type L1210 cells expressing mutant p53 and drug-resistant L1210 cells lacking expression of p53: necrosis vs. apoptosis.

Cory AH, Chen J, Cory JG. Cory AH, et al. Anticancer Res. 2006 Mar-Apr;26(2A):1289-95. Anticancer Res. 2006. PMID: 16619536 Free article.

8

Use of nucleoside kinase-deficient mouse leukemia L1210 cell lines to determine metabolic routes of activation of antitumor nucleoside analogs.

Cory AH, Cory JG. Cory AH, et al. Among authors: cory jg. Adv Enzyme Regul. 1994;34:1-12. doi: 10.1016/0065-2571(94)90005-1. Adv Enzyme Regul. 1994. PMID: 7942266

9

Substituted 2-acylpyridine-alpha-(N)-hetarylhydrazones as inhibitors of ribonucleotide reductase activity and L1210 cell growth.

Cory JG, Downes DL, Cory AH, Schaper KJ, Seydel JK. Cory JG, et al. Among authors: cory ah. Anticancer Res. 1994 May-Jun;14(3A):875-9. Anticancer Res. 1994. PMID: 8074487

10

2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture.

Cory AH, Samano V, Robins MJ, Cory JG. Cory AH, et al. Among authors: cory jg. Biochem Pharmacol. 1994 Jan 20;47(2):365-71. doi: 10.1016/0006-2952(94)90028-0. Biochem Pharmacol. 1994. PMID: 8304981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters